| Ulva lactuca polysaccharides prevent Wistar rat breast carcinogenesis through the augmentation of apoptosis, enhancement of antioxidant defense system, and … GEF Abd-Ellatef, OM Ahmed, ES Abdel-Reheim, AHZ Abdel-Hamid Breast Cancer: Targets and Therapy, 67-83, 2017 | 96 | 2017 |
| Curcumin-loaded solid lipid nanoparticles bypass p-glycoprotein mediated doxorubicin resistance in triple negative breast cancer cells GE Fathy Abd-Ellatef, E Gazzano, D Chirio, A Ragab Hamed, ... Pharmaceutics 12 (2), 96, 2020 | 87 | 2020 |
| Light-regulated NO release as a novel strategy to overcome doxorubicin multidrug resistance K Chegaev, A Fraix, E Gazzano, GEF Abd-Ellatef, M Blangetti, B Rolando, ... ACS Medicinal Chemistry Letters 8 (3), 361-365, 2017 | 44 | 2017 |
| Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer IC Salaroglio, E Gazzano, A Abdullrahman, E Mungo, B Castella, ... Journal of Experimental & Clinical Cancer Research 37, 1-20, 2018 | 41 | 2018 |
| Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein GEF Abd-Ellatef, E Gazzano, AH El-Desoky, AR Hamed, J Kopecka, ... Pharmacological Research 175, 105975, 2022 | 15 | 2022 |
| Antiproliferative, antioxidant and antimicrobial activities of phenolic compounds from Acrocarpus fraxinifolius AIEGEFAE Walaa A. El-Kashak1, Ahmed R. Hamed, Mohamed El-Raey Journal of Chemical and Pharmaceutical Research 8 (3), 520-528, 2016 | 9 | 2016 |
| Differential effects of c-myc and ABCB1 silencing on reversing drug resistance in HepG2/Dox cells SMM Yahya, AR Hamed, M Emara, MM Soltan, GEF Abd-Ellatef, ... Tumor Biology 37, 5925-5932, 2016 | 8 | 2016 |
| Promising anticancer activity of pomegranate peels extract (PPE) against bacterial pathogens-induced colon cancer in mice model NM Ammar, HA Hassan, M Elkady, MAI Maamoun, GE Fathy Abd-Ellatef, ... Egyptian Journal of Chemistry 66 (13), 1259-1277, 2023 | | 2023 |
| Correction to “Light-Regulated NO Release as a Novel Strategy To Overcome Doxorubicin Multidrug Resistance” K Chegaev, A Fraix, E Gazzano, GEF Abd-Ellatef, M Blangetti, B Rolando, ... ACS Medicinal Chemistry Letters 10 (3), 393-393, 2019 | | 2019 |
